Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Italian Trials of Medical Oncology (ITMO) is a prominent Italian cooperative research group dedicated to the design, conduct, and coordination of clinical trials in the field of oncology. Founded to improve cancer treatment standards through independent clinical research, the organization collaborates with a vast network of hospitals and research centers across Italy. ITMO focuses on evaluating new therapeutic strategies, including targeted therapies, immunotherapies, and optimized chemotherapy regimens, across various solid tumors such as breast, lung, and colorectal cancers. The group plays a significant role in advancing evidence-based medicine and contributing to international oncological guidelines. By facilitating multi-center studies, ITMO ensures that innovative treatments are rigorously tested in diverse patient populations. Its work is essential for the integration of new scientific discoveries into clinical practice within the Italian healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Italian Trials of Medical Oncology.